- Home
- LITB vs ANEB Comparison
LITB vs ANEB Comparison
Compare LITB & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LITB
- ANEB
- Stock Information
- Founded
- LITB 2007
- ANEB 2020
- Country
- LITB Singapore
- ANEB United States
- Employees
- LITB N/A
- ANEB N/A
- Industry
- LITB Catalog/Specialty Distribution
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- LITB Consumer Discretionary
- ANEB Health Care
- Exchange
- LITB Nasdaq
- ANEB Nasdaq
- Market Cap
- LITB 36.4M
- ANEB 111.8M
- IPO Year
- LITB N/A
- ANEB 2021
- Fundamental
- Price
- LITB $3.58
- ANEB $2.71
- Analyst Decision
- LITB
- ANEB Buy
- Analyst Count
- LITB 0
- ANEB 2
- Target Price
- LITB N/A
- ANEB $8.00
- AVG Volume (30 Days)
- LITB 31.0K
- ANEB 22.3K
- Earning Date
- LITB 12-09-2025
- ANEB 11-14-2025
- Dividend Yield
- LITB N/A
- ANEB N/A
- EPS Growth
- LITB N/A
- ANEB N/A
- EPS
- LITB 0.12
- ANEB N/A
- Revenue
- LITB $220,656,000.00
- ANEB N/A
- Revenue This Year
- LITB N/A
- ANEB N/A
- Revenue Next Year
- LITB N/A
- ANEB N/A
- P/E Ratio
- LITB $27.27
- ANEB N/A
- Revenue Growth
- LITB N/A
- ANEB N/A
- 52 Week Low
- LITB $0.91
- ANEB $0.80
- 52 Week High
- LITB $3.77
- ANEB $3.42
- Technical
- Relative Strength Index (RSI)
- LITB 74.62
- ANEB 60.42
- Support Level
- LITB $2.54
- ANEB $2.50
- Resistance Level
- LITB $3.40
- ANEB $2.76
- Average True Range (ATR)
- LITB 0.39
- ANEB 0.13
- MACD
- LITB 0.10
- ANEB 0.02
- Stochastic Oscillator
- LITB 90.10
- ANEB 76.27
About LITB LightInTheBox Holding Co. Ltd.
LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company operates in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of provision of logistic services to companies and to individual customers. It derives maximum revenue from Product Sales. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.